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F u n c t i o n a lf o o d sa r ed e f i n e da sf o o d st h a tp r o v i d e
health benefits in addition to their basic nutritional
value. These additional health benefits form the basis
for producers’ health claims on foods. Legislation
demands that health claims should be based on and
substantiated by generally accepted scientific evidence.
The main topic of this presentation will be how the Eur-
opean Food Safety Authority (EFSA) approaches the
issue of scientific substantiation of health claims on
foods. Health claims can be categorized in different
ways, but basically they will be of two types, namely
those relating to maintaining or improving a biological
function (‘function claims’), and those relating to reduc-
tion of a disease risk factor (‘risk reduction claims’). Dis-
ease itself can not be used as the formal end point, and
claims on treatment or cure of disease can not be made.
The target population of the health claim must be speci-
fied, and essential criteria are that the claim must be
sufficiently specific to allow evaluation, the claim must
represent a beneficial physiological effect, the food/food
component for which the claim is made must be suffi-
ciently well characterised, and last but not least there
must be sufficient scientific evidence to substantiate the
claim. All the criteria must be met. Scientific evidence is
evaluated according to standard criteria for good
science. The ongoing work in EFSA, with evaluation of
some 4000 health claims, is an important step to secure
that health claims on products in the marketplace are
based on by sound, convincing scientific evidence, and
that the claims will not soon have to be re-evaluated in
light of new scientific data. Securing that claims are
truthful, accurate and not misleading is expected over
time to increase consumers’ trust in health claims on
foods, and thereby supposedly also the use of products
bearing health claims.
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